On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...